Abstract |
Growth arrest-specific protein 6 (Gas6) is a serum protein involved in granulocyte, platelet and endothelium interaction, and is implicated in both anti-inflammatory response as well as platelet/leukocytes activation. We investigated serum Gas6 level in different clinical manifestations of systemic lupus erythematosus (SLE). Data were collected in 83 patients with SLE and 40 non-lupus controls. The Gas6 levels were detected by enzyme-linked immunosorbent assay. Our results demonstrated that the Gas6 level was higher in SLE patients as compared to the non-lupus control subjects (SLE vs. non-lupus control, median [inter-quartile range (IQR)] 22.67 [19.40-28.60] vs. 18.97 [16.05-20.62] ng/mL, p < 0.01). Furthermore, Gas6 level was higher in patients with nephritis ( nephritis vs. non- nephritis, median [IQR] 26.21 [21.17-31.61] vs. 22.22 [18.98-26.98] ng/mL, p = 0.03) and in patients with cutaneous vasculitis ( vasculitis vs. non- vasculitis, median [IQR] 27.89 [23.24-34.26] vs. 22.30 [19.32-27.16] ng/mL, p = 0.03). Our results indicate that the serum Gas6 level is increased in SLE patients with lupus nephritis or cutaneous vasculitis, implicating a potential to serve as a SLE disease activity marker.
|
Authors | Chien-Sheng Wu, Chung-Yi Hu, Hwei-Fang Tsai, I-Tsu Chyuan, Cheng-Ju Chan, Sheng-Kai Chang, Ping-Ning Hsu |
Journal | Rheumatology international
(Rheumatol Int)
Vol. 34
Issue 5
Pg. 625-9
(May 2014)
ISSN: 1437-160X [Electronic] Germany |
PMID | 24178067
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Biomarkers
- Intercellular Signaling Peptides and Proteins
- growth arrest-specific protein 6
|
Topics |
- Adult
- Biomarkers
(blood)
- Case-Control Studies
- Disease Progression
- Female
- Humans
- Intercellular Signaling Peptides and Proteins
(blood)
- Lupus Erythematosus, Systemic
(blood, diagnosis)
- Lupus Nephritis
(blood, diagnosis)
- Male
- Middle Aged
- Prognosis
- Up-Regulation
- Vasculitis
(blood, diagnosis)
|